Mesoblast (MEOBF) Exchange Rate Effect (2014 - 2024)
Mesoblast's (MEOBF) quarterly Exchange Rate Effect came in at $78000.0 in Q2 2024, up 25.81% year-over-year from $62000.0 in Q3 2023, and up 25.81% quarter-over-quarter from $62000.0 in Q2 2023.
Powered by 
Analysis
Mesoblast (MEOBF) Exchange Rate Effect (2014 - 2024) Analysis & Trends
Mesoblast has disclosed Exchange Rate Effect across 11 years of filings, most recently posting $78000.0 for Q2 2024.
- In Q2 2024, Exchange Rate Effect rose 25.81% year-over-year to $78000.0; the TTM figure through Jun 2024 stood at -$556000.0 (down 327.69% YoY), while the FY2026 annual figure was -$1.2 million, down 5143.48% from the prior year.
- Exchange Rate Effect came in at $78000.0 for Q2 2024 at Mesoblast, up from $62000.0 in the prior quarter.
- In the past five years, Exchange Rate Effect ranged from a high of $1.1 million in Q4 2020 to a low of -$385000.0 in Q1 2023.
- Average Exchange Rate Effect over 5 years is $80142.9, with a median of $35000.0 recorded in 2022.
- Year-over-year, Exchange Rate Effect soared 1265.12% in 2020 and tumbled 7700.0% in 2022.
- Over 5 years, Exchange Rate Effect stood at $1.1 million in 2020, then slumped by 93.4% to $75000.0 in 2021, then plunged by 514.67% to -$311000.0 in 2022, then surged by 119.94% to $62000.0 in 2023, then climbed by 25.81% to $78000.0 in 2024.
- Per Business Quant data, the three most recent Exchange Rate Effect figures were $78000.0 in Q2 2024, $62000.0 in Q2 2023, and -$385000.0 in Q1 2023.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Krystal Biotech | 10.27 Bn | 9.43 Bn | 112.79 Mn | -1.83 Mn |
| 2 | CRISPR Therapeutics AG | 5.17 Bn | 5.17 Bn | - | 6,000.00 |
| 3 | Iovance Biotherapeutics | 3.79 Bn | 3.49 Bn | 55.72 Mn | -124,000.00 |
| 4 | Legend Biotech | 3.68 Bn | 2.71 Bn | 251.50 Mn | -300,000.00 |
| 5 | uniQure | 3.05 Bn | 3.05 Bn | 5.49 Mn | -774,000.00 |
| 6 | Beam Therapeutics | 2.65 Bn | 2.65 Bn | - | - |
| 7 | Precigen | 2.44 Bn | 2.44 Bn | 52.17 Mn | 1,000.00 |
| 8 | Sarepta Therapeutics | 2.33 Bn | 1.53 Bn | 251.87 Mn | - |
| 9 | Vericel | 1.99 Bn | 1.83 Bn | 56.40 Mn | - |
| 10 | Mesoblast | 246.02 Mn | 143.11 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2024 | 78,000.00 |
| Jun 30, 2023 | 62,000.00 |
| Mar 31, 2023 | -385,000.00 |
| Dec 31, 2022 | -311,000.00 |
| Sep 30, 2022 | 504,000.00 |
| Jun 30, 2022 | -156,000.00 |
| Mar 31, 2022 | 8,000.00 |
| Dec 31, 2021 | 75,000.00 |
| Sep 30, 2021 | 122,000.00 |
| Jun 30, 2021 | -2,000.00 |
| Mar 31, 2021 | -220,000.00 |
| Dec 31, 2020 | 1.14 Mn |
| Sep 30, 2020 | 501,000.00 |
| Mar 31, 2020 | -290,000.00 |
| Dec 31, 2019 | 328,000.00 |
| Sep 30, 2019 | -43,000.00 |
| Mar 31, 2019 | 56,000.00 |
| Dec 31, 2018 | -126,000.00 |
| Sep 30, 2018 | -143,000.00 |
| Jun 30, 2018 | -139,000.00 |